Tremendous progress has been made in the field of hemolytic uremic syndrome in the last decade. The role of the alternate pathway of complement activation is understood to be central to the pathogenesis of atypical HUS. As a part of an ongoing research project funded by the Department oif Biotechnology, Government of India, testing is available for complement factor H, anti-complement factor H antibodies and membrane cofactor protein (CD46) at the Department of Pediatrics, All India Institute of Medical Sciences, New Delhi.
If you wish to examine for these abnormalities in a patient with atypical HUS, you should send the following blood specimens:
2 EDTA vial (purple cap), 4-5 ml blood each vial.
The samples should be sent at room temperature along with the following forms
Patient information sheet and informed consent form
Case record form
3053, Teaching Block
Division of Nephrology, Department of Pediatrics
All India Institute of Medical Sciences
Ansari Nagar, New Delhi-110029
Phone no 011-26593472, 011-26594858